.jpg)
Kate Cox is one of hundreds in Texas denied abortions despite serious health risks, data show
A Texas woman’s unsuccessful legal fight for an abortion on medical emergency grounds drew nationwide…
Category: Medicine
Opinion: The federal government fails to provide Americans with reproductive health information they need. Here’s a better approach
Soon after the end of Roe v. Wade, President Biden issued an executive order attempting…
STAT+: Sanders blames food companies for diabetes epidemic
WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry. Sanders…
STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors
In a bid toward greater transparency, the U.S. Food and Drug Administration earlier this month…
Listen: FTC v. biotech, Pfizer’s kitchen sink, & Vertex’s future
Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally…
STAT+: Amputees have better balance, less pain after electrical stimulation, study finds
For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower…
North Carolina attorney general sues HCA for lapses at Mission Health
North Carolina’s attorney general alleges in a new lawsuit that HCA Healthcare is violating the…
STAT+: Why FDA product recalls have spiked in recent years
Either American products are getting worse, or scrutiny over their safety is getting tougher. Whichever…
Morning Rounds: Teen pregnancies down, but remain higher in the U.S.
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT+: Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts
Jay Bradner, a former top research leader at Novartis, is joining Amgen as its new…
STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
Is it time to worry about Moderna?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Health records don’t always show when patients are dead. One researcher is trying to change that
Health professor Neil Wenger was deep into a years-long study on seriously ill primary care…
Opinion: Europe’s lessons for the U.S. on how to cover weight loss drugs
It’s no secret that the obesity epidemic in the United States has reached alarming levels,…
When Dobbs forced one doctor to shutter his abortion clinic, he took his mission on the road
On June 24, 2022, Aaron Campbell turned away patients at his abortion clinic for the…
.jpg)
Opinion: In mifepristone case, the Supreme Court must affirm the FDA’s authority. Medical innovation is at risk
On Wednesday, the Supreme Court announced it will soon weigh in on a case that…
STAT+: Bankrupt Pear’s addiction treatments acquired by virtual care company
Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital…
STAT+: New federal rules demand transparency into AI models used in health decisions
Federal health technology regulators on Wednesday finalized new rules to force software vendors to disclose…
Opinion: Exceptions to abortion restrictions often fail people like Kate Cox whose babies are sure to die
Imagine being in the midst of your pregnancy, and you learn that your baby is…
STAT+: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in
For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight…
Supreme court will decide abortion pill access
WASHINGTON — The Supreme Court agreed Wednesday to take on whether Americans can access a…
Morning Rounds: For kids with high BMI, task force not ready to recommend weight loss drugs
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
A plot to solve the ‘whack-a-mole’ of drug discovery
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pfizer says 2024 profits will fall far below expectations
Pfizer said Wednesday that its 2024 profits would fall far below investor expectations, leading shares…
STAT+: Vertex non-opioid drug reduces chronic nerve pain in mid-stage study
Vertex Pharmaceuticals said Wednesday that an experimental drug reduced pain in people with diabetes who…
STAT+: Male birth control gets another shot with small new trial of non-hormonal pill
From several types of hormonal pills to implants, IUDs, and vaginal rings, women have a…
Opinion: Listen: When do tests hurt more than help?
Manil Suri and Daniel Morgan are an unusual team: Manil is a mathematics professor and…
Opinion: Sobering centers offer a safe place to recover from intoxication. Every community should have one
Every day, thousands of individuals across the United States call 911 due to concern about…
Gene therapy offered this 7-year-old freedom. The price: a grueling year
PHILADELPHIA — The meds Shelby Campbell needed for her rare blood disorder stopped working just…
Doctors call out ableism in cancer care: ‘The biggest accommodation is attitude’
People with disabilities often spend a lot of time navigating bias and educating others about…
STAT+: Could sickle cell someday be treated not with CRISPR, but with a pill?
Two gene therapies were approved for sickle cell disease last week, but for many researchers…
STAT+: Humana used algorithm in ‘fraudulent scheme’ to deny care to Medicare Advantage patients, lawsuit alleges
Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant…
STAT+: Maze CEO ‘personally disappointed’ in Sanofi decision to terminate partnership
When Sanofi terminated its partnership with Maze Therapeutics this week to develop an experimental drug…
STAT+: A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients
SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration…
STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease
SAN DIEGO — The sickle cell community has for the past few days been buzzing…
STAT+: Late-stage trial supports broader use of Darzalex, blockbuster J&J multiple myeloma drug
SAN DIEGO — Johnson & Johnson’s multiple myeloma therapy, Darzalex, is already a blockbuster. Now…
Morning Rounds: Can you take GLP-1 drugs during pregnancy?
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound
Top of the morning to you. And a fine one it is. Lots of sunshine…
Tome Biosciences goes public today in another biotech megaround
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Methadone clinics spar with addiction doctors on bill that would widen access
Lawmakers on Tuesday will debate an addiction medicine proposal that would have been considered unthinkable…
Boston’s mobile clinics offer model of health care that meets patients where they are
BOSTON — Chongcan Zhu, an 83-year-old longtime resident of Boston, lives alone — but she…
STAT+: With big ambition — and a family name to match — Reed Jobs charts his own course in biotech
In the months after his father died of complications from pancreatic cancer, Reed Jobs found…
Opinion: New sickle cell disease CRISPR treatments can’t make up for the shortage of adult hematologists
After decades of limited progress in the treatment of sickle cell disease (SCD), both patients…
Opinion: It’s time to rethink the Medicare annual wellness visit
In 2011, the Centers for Medicare and Medicaid Services created the annual wellness visit (AWV),…
House passes site-neutral policy, transparency, PBM reform package
WASHINGTON — The House passed a relatively major health care package late Monday, an end-of-year…
STAT+: UnitedHealth executive to head health insurance group AHIP
WASHINGTON — An executive at insurance giant UnitedHealth Group is slated to be the next…
STAT+: Sanofi ends deal for a rare disease drug after FTC voices monopoly concerns
In its latest bid to police the pharmaceutical industry, the U.S. Federal Trade Commission sought…
STAT+: Hot antitrust environment hangs over called-off merger between Cigna and Humana
Less than two weeks after reports surfaced saying Cigna and Humana were considering combining into…
Opinion: STAT+: Dana-Farber CEO Laurie Glimcher has always been a trailblazer and a risk taker
Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in…